<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for South Somerset East - Rpn PCN</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where South Somerset East - Rpn PCN is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0212000AI&amp;denomIds=2.12&amp;selectedTab=summary">Alirocumab</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Lipid-regulating drugs</td>
      <td>19077</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>23.55</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0212000AIAAAAAA&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Alirocumab 75mg/1ml inj pre-filled disposable devices : 3</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0212000AIAAABAB&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Alirocumab 150mg/1ml inj pre-filled disposable devices : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0301040AA&amp;denomIds=3.1.4&amp;selectedTab=summary">Glycopyrronium/formoterol</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>12</td>
      <td>Compound bronchodilator preparations</td>
      <td>510</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>6.40</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0301040AAAAAAAA&amp;denomIds=3.1.4&amp;selectedTab=summary" target="_blank">Glycopyrronium 7.2microg/Formoterol 5microg/dose inh CFCfree : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0301040AABBAAAA&amp;denomIds=3.1.4&amp;selectedTab=summary" target="_blank">Bevespi Aerosphere 7.2microg / 5microg/dose pressurised inh : 11</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0205040V0&amp;denomIds=2.5.4&amp;selectedTab=summary">Terazosin hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>93</td>
      <td>Alpha-adrenoceptor blocking drugs</td>
      <td>1810</td>
      <td>0.05</td>
      <td>0.01</td>
      <td>0.01</td>
      <td>5.85</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAGTklEQVR4nO3daagVdRzG8e+krWYLpRGUDrnQ8iKJICyxImgb31QkREZvQtCCXmQ2lUSR0JQlZULRYiImlC0SDm2kBZEULUYrZjRlZKhUZpll+uvFfy5dpbPcZj1nng8c5njPMM//XO9zZu6c/5nrmRki0gwHVD0AESmPCi/SICq8SIOo8CINosKLNIgKL9IgKrxIg6jwIg2iwos0iAov0iAqvJTD8zSHuwaG57UhP4xPBq4GxgFjgXuSKFid1/ZFJDsvjw/P+GE8DPgAWA58BPwGrABmJFGwLnOA9D7PM8y8qofRdHkVfiYwNYmCGYO+Ngl4EbgkiYIvM4dIb1PhayHz7/B+GB8J3AqEg7+eRMF64DrgJT+Mj86aIyLZ5XHSbh6wNImC7/d/IImCN4BlwB055IhIRnkU/jJgQZvHHwCmpSf1RKRCeRR+cRIFO1s9mETBH8BtwMIcskQkgzwKv7KLdZ4DRvhhfGkOeSLyP+Vylr4b6Vn7FcCkJAr+KiVU6kNn6WuhtJl26Vn7t4Hry8oUkX2VPbV2HnCjH8ajSs4VEUoufBIFW4BFwN1l5oqIU8WHZxYDU/0wPr2CbJFGK73w6Qm7m4HFfhjr03oiJaqkcEkUxMAPwOwq8kWaqso97A3ATX4Yn1ThGEQapbLCJ1GwFZgLPKlDe5FyVFq0JApWAttwe3sRKVgd9qyzgNl+GJ9f9UBE+l1pU2vb8cP4VCAGLkyi4KuqxyMF0NTaWqjDHp4kCj7H7elX6WIZIsWpReEBkih4BTcp51U/jI+pejwi/ag2hQdIouARYAmwxg/j46oej0i/qVXhAZIoeBR3lZw1fhiPrXo8Iv2kdoUHSKJgGXA7sNYP48lVj0ekX9Sy8ABJFKwCrgCW+WE8o9P6ItJZLd6Wa8cP4+OBF4D3gJt1tZwepbflaqG2e/gBSRRsBs4FPOAtP4zHVDwkkZ5V+z38YH4YTwfuw/1+vyKJgt4ZfNNpD18LPVV4gPTM/RO4v183K4mCHyseknRDha+Fnis8gB/GHjATd737p4CFSRT8Wu2opC0VvhZ6svAD/DA+CpgDXAMsBZZrLn5NqfC10NOFH+CH8WjgWtzfp/8LWA28A7ybRMGOKscmKRW+Fvqi8IP5YXwacAFwNnAWYMAG4Kt0uQHYCGzSW3wlUuFroe8Kvz8/jEcC44GJwIR0OR44MV1lE/At8F26HLi/BdieRMGussfcl1T4Wuj7wrfjh/FBwAnAWGBMuhy4HQscCRyMmwPwO7Ad2AX8OWjZ6v4uYCfu3YTfgB2D7u9zS6Lg78KfbNVU+FpodOG7lb4rMAI4AjgE9yIwsGx1/xDgMODwFreRg+4PT6N20eJFIb3txb340MVygHWxtHTbe4a43P9rg7e1z/3k3mnP+resvqLFOt2M8b+WWbX73g3l+1zpC1kSBS91vbKZZboBM7NuQ1nlZPXjc9L3b2i3PKbWzsxhG8rqr5x+zer551T7ufQikh8VXqRB8ij8YzlsQ1n9ldOvWT3/nHSWXqRBdEgv0iDDO6/yL8/zpuKmrG4xsyWe510OjMNNVf0MN5f9ZzN7MOvAOmR9A0RmdnHWnC6yfkkf22FmiwrM2QhcBOw2s4ey5HTKMrMXPc+7ChhrZlGRWbj3zM8E1pjZmgJz1uHObH9tZk9nyekiaxMwBTjbzKYXnLUVdwGYo81sTtasoe7hJ6c/IKPSf08wswW46aoBMB836SQPLbPMbD3wZk45nbLWAhGQx7Xy2+V8gvv/ODSHnLZZnuedBmzOKadtFm6G4m7cRKQic67EzYTcm0NO2ywzex94FlhbdBZu1uZo3KzNzIZa+P1/4S/yBECdsuYCjxedY2b3AXl9rr9d1mRgEnBO0Vlm9rqZ3QWcUWQOcCDwMnBKDjmdssBdYPX5ErIm4q7wtDuPoCGdtEsPPSYDPwEf4uacj8N9Eu0L4CrcIX1eh6Stsj4GFgHLzeyZgrOOwx2SvmZmKwvM+T19bKeZ3Z8lp1OWma1K1wlzPKRv9by2AecB283s4QJzPsV9RHqPmd2ZJadTlpmt8jxvvpnNy5rTKQv3czEFGJZHns7SizSIztKLNIgKL9IgKrxIg6jwIg2iwos0iAov0iAqvEiDqPAiDaLCizSICi/SICq8SIP8A+STlUahrdIFAAAAAElFTkSuQmCC"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0205040V0AAABAB&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Terazosin 2mg tablets : 30</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0205040V0AAACAC&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Terazosin 5mg tablets : 22</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0205040V0AAADAD&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Terazosin 10mg tablets : 41</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0702010M0&amp;denomIds=7.2.1&amp;selectedTab=summary">Ospemifene</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>7</td>
      <td>Preparations for vaginal/vulval changes</td>
      <td>759</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.35</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0702010M0AAAAAA&amp;denomIds=7.2.1&amp;selectedTab=summary" target="_blank">Ospemifene 60mg tablets : 7</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0208010AB&amp;denomIds=2.8.1&amp;selectedTab=summary">Fondaparinux sodium</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Parenteral anticoagulants</td>
      <td>56</td>
      <td>0.11</td>
      <td>0.01</td>
      <td>0.02</td>
      <td>5.01</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0208010ABAAAAAA&amp;denomIds=2.8.1&amp;selectedTab=summary" target="_blank">Fondaparinux sodium 2.5mg/0.5ml inj pre-filled syringes : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0208010ABAAABAB&amp;denomIds=2.8.1&amp;selectedTab=summary" target="_blank">Fondaparinux sodium 5mg/0.4ml inj pre-filled syringes : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0208010ABAAACAC&amp;denomIds=2.8.1&amp;selectedTab=summary" target="_blank">Fondaparinux sodium 7.5mg/0.6ml inj pre-filled syringes : 4</a></div></td></tr></tbody></table>

        <h2>Prescribing where South Somerset East - Rpn PCN is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0205040D0&amp;denomIds=2.5.4&amp;selectedTab=summary">Doxazosin mesilate</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1717</td>
      <td>Alpha-adrenoceptor blocking drugs</td>
      <td>1810</td>
      <td>0.95</td>
      <td>0.99</td>
      <td>0.01</td>
      <td>-3.87</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0205040D0AAAAAA&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 1mg tablets : 211</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0205040D0AAABAB&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 2mg tablets : 535</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0205040D0AAACAC&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 4mg tablets : 698</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0205040D0AAAQAQ&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 4mg modified-release tablets : 114</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0205040D0AAARAR&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 8mg modified-release tablets : 78</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0205040D0AABBBB&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 8mg tablets : 21</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0205040D0BDACAC&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxadura 4mg tablets : 33</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0205040D0BDADAQ&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxadura XL 4mg tablets : 27</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0605010S0&amp;denomIds=6.5.1&amp;selectedTab=summary">Somatropin</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Hypothalamic &amp; anterior pituitary hormone &amp; antioestrogens</td>
      <td>10</td>
      <td>0.00</td>
      <td>0.89</td>
      <td>0.25</td>
      <td>-3.49</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0403030Q0&amp;denomIds=4.3.3&amp;selectedTab=summary">Sertraline hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3010</td>
      <td>Selective serotonin re-uptake inhibitors</td>
      <td>9675</td>
      <td>0.31</td>
      <td>0.46</td>
      <td>0.06</td>
      <td>-2.55</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0403030Q0AAAAAA&amp;denomIds=4.3.3&amp;selectedTab=summary" target="_blank">Sertraline 50mg tablets : 1714</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0403030Q0AAABAB&amp;denomIds=4.3.3&amp;selectedTab=summary" target="_blank">Sertraline 100mg tablets : 1283</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0403030Q0AAAQAQ&amp;denomIds=4.3.3&amp;selectedTab=summary" target="_blank">Sertraline 50mg/5ml oral suspension : 5</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0403030Q0AAAZAZ&amp;denomIds=4.3.3&amp;selectedTab=summary" target="_blank">Sertraline 25mg tablets : 8</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0206040AE&amp;denomIds=2.6.4&amp;selectedTab=summary">Naftidrofuryl oxalate</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Peripheral vasodilators and related drugs</td>
      <td>3</td>
      <td>0.00</td>
      <td>0.67</td>
      <td>0.28</td>
      <td>-2.38</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U81307&amp;numIds=0906050P0&amp;denomIds=9.6.5&amp;selectedTab=summary">Vitamin E</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Vitamin E</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.73</td>
      <td>0.33</td>
      <td>-2.24</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>